Company: MDCXW
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001062993-25-011673
Chunk: 25

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 25
---
); Chairman and CEO, Raju LLP (2021 - Present)                                           |     | N/A            |     |  2,000,000 (9) |
| Dr. Raza      
 Bokhari (3)   
 Pennsylvania, 
 United States |     |  58 |     | Executive Chairman and Chief Executive Officer |     | Executive Chairman and Chief Executive Officer, Medicus Pharma Ltd. (2023 - present); Executive Chairman and CEO, FSD Pharma (2020 - 2021) |     | September 2023 |     |      1,068,173 |

Notes:

| (1) |     | Member of the Compensation Committee. Mr. Lavelle is the Chair.                                                                                                                                                        |
| (2) |     | Member of the Audit Committee. Mr. Ciaruffoli is the Chair.                                                                                                                                                            |
| (3) |     | Member of the Corporate Disclosure Committee. Mr. Ciaruffoli is the Chair.                                                                                                                                             |
| (4) |     | Member of the Governance Committee. Mr. Fishman is the Chair.                                                                                                                                                          |
| (5) |     | Member of the Nominating Committee. Dr. Kaiser is the Chair.                                                                                                                                                           |
| (6) |     | The information as to principal occupation, business or employment is not within the knowledge of the Company and has been furnished by the respective current directors and director nominees, as the case may be.    |
| (7) |     | Including options that are currently exercisable or will become exercisable within 60 days of June 2, 2025 by each director.                                                                                           |
| (8) |     | Nominated for the first time as a director of the Company.                                                                                                                                                             |
| (9) |     | Includes 2,000,000 Common Shares held of record by 215 Capital Togo PHL Fund I, LP, an entity controlled by Ajay Raju. Mr. Raju's address is Two Liberty Place, 50 S. 16th Street, Suite 2710, Philadelphia, PA 19102. |

Biographical Information

The biographies of the proposed nominees for the Board are set out below.

Dr. Raza Bokhari, Executive Chairman and Chief Executive Officer

Dr. Bokhari has served as our Executive Chairman and Chief Executive Officer since September 2023. Dr. Bokhari works full time for the Company.

A recipient of Philadelphia Business Journal's "40 under 40